1.Date of the board of directors resolution:2025/02/19

2.General shareholders' meeting date:2025/05/16

3.General shareholders' meeting location:TOP PHARM. MEDICALWARE COMPANY LIMITED(20F., No. 499, Zhongming S. Rd., West Dist., Taichung City, Taiwan(R.O.C.))

4.Cause for convening the meeting I.Reported matters:
(1)Year 2024 Business Report
(2)Supervisors' Review Report on the year 2024 Financial Statements
(3)Report on Employee's and Directors' Remuneration for the year 2024
(4)Report on the merger of TOP Biological Technology Company

5.Cause for convening the meeting II.Acknowledged matters:
(1)Year 2024 Business Report and Financial Statements
(2)Year 2024 Earnings Distribution

6.Cause for convening the meeting III, Matters for Discussion:
(1)Approved of the new share issue through capitalization of earnings.
(2)Approved of the amendment of ”Articles of Incorporation”
(3)Approved of the release the prohibition on Directors from participation incompetitive business.

7.Cause for convening the meeting IV.Election matters:None

8.Cause for convening the meeting V.Other Proposals:None

9.Cause for convening the meeting VI.Extemporary Motions:None

10.Book closure starting date:2025/04/17

11.Book closure ending date:2025/05/16

12.Any other matters that need to be specified:Pursuant to Article 172-1 of the Company Act, a shareholder may submit a written proposal for discussion at a regular shareholders' meeting from 2025/04/01 to 2025/04/11 17:00.
Location for shareholders' submission of proposal:20F., No. 499, Zhongming S. Rd., West Dist., Taichung City, Taiwan(R.O.C.)
Tel:(04)2375-9099